A single dose SARS-CoV-2 simulating particle vaccine induces potent neutralizing activities
By
Di Yin,
Sikai Ling,
Xiaolong Tian,
Yang Li,
Zhijue Xu,
Hewei Jiang,
Xue Zhang,
Xiaoyuan Wang,
Yi Shi,
Yan Dora Zhang,
Lintai Da,
Sheng-Ce Tao,
Quanjun Wang,
Jianjiang Xu,
Tianlei Ying,
Jiaxu Hong,
Yujia Cai
Posted 15 May 2020
bioRxiv DOI: 10.1101/2020.05.14.093054
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for which a vaccine is urgently needed to control its spreading. To facilitate the representation of a native-like immunogen without being infectious, here, we reported a SARS-CoV-2 vaccine candidate (designated ShaCoVacc) by incorporating spike-encoding mRNA inside and decorating spike protein on the surface of the virus simulating particles (VSPs) derived from lentiviral particles. We characterized the mRNA copy number, glycosylation status, transduction efficiency, and innate immune property of the new vaccine platform. Importantly, we showed the ShaCoVacc induced strong spike-specific humoral immune responses and potent neutralizing activities by a single injection. Additionally, we disclosed the epitopes of spike-specific antibodies using peptide microarray and revealed epitopes susceptible to specific neutralizing antibodies. These results support further development of ShaCoVacc as a candidate vaccine for COVID-19 and VSP may serve as a new vaccine platform for emerging infectious diseases. ### Competing Interest Statement The authors have declared no competing interest.
Download data
- Downloaded 3,225 times
- Download rankings, all-time:
- Site-wide: 5,866
- In bioengineering: 64
- Year to date:
- Site-wide: 31,794
- Since beginning of last month:
- Site-wide: 35,509
Altmetric data
Downloads over time
Distribution of downloads per paper, site-wide
PanLingua
News
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!